Mylene P. Jansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mylene P. Jansen has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
- Simon C. Mastbergen
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
22 shared publications - Francisco Javier Blanco
INIBIC
12 shared publications Simon C. Mastbergen
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
12 shared publications- Francis Berenbaum
Rheumatology, Sorbonne University, INSERM CRSA, AP-HP Saint-Antoine Hospital Paris, France
10 shared publications - Ida Kristin Haugen
Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway
10 shared publications Margreet Kloppenburg
Affiliation Rheumatology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, The Netherlands
9 shared publications
Latest Publications
- Open Access
- 12 April 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 200, 112856
The influence of weight-bearing and flexion on 3D joint space width and cartilage thickness in knee osteoarthritis: a rotatable MRI study
- 12 April 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 200, 112856
Open AccessThe influence of weight-bearing and flexion on 3D joint space width and cartilage thickness in knee osteoarthritis: a rotatable MRI study
- Open Access
- 5 March 2026
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (2) , 100762
Progression of bone and joint space deformity in patients with mild knee osteoarthritis: Data from the IMI-APPROACH cohort
- 5 March 2026
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (2) , 100762
Open AccessProgression of bone and joint space deformity in patients with mild knee osteoarthritis: Data from the IMI-APPROACH cohort
- Open Access
- 11 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (1) , 100726
How are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohort
- 11 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (1) , 100726
Open AccessHow are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohort
- Open Access
- 6 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 601-606
Does spontaneous cartilage thickening occur in osteoarthritic knees? Data from IMI-APPROACH and the OAI
- 6 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 601-606
Open AccessDoes spontaneous cartilage thickening occur in osteoarthritic knees? Data from IMI-APPROACH and the OAI
- Open Access
- 28 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (2) , 297-303
Unicompartmental versus bicompartmental joint space width measures: Which reflect whole joint structural damage better? Data from IMI-APPROACH
- 28 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (2) , 297-303
Open AccessUnicompartmental versus bicompartmental joint space width measures: Which reflect whole joint structural damage better? Data from IMI-APPROACH
- 17 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (1) , 28-38
Osteoarthritis year in review 2025: Imaging
- 17 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (1) , 28-38
Osteoarthritis year in review 2025: Imaging
- Open Access
- 12 October 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (5) , 672-678
Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? – Data from the FNIH and IMI-APPROACH cohorts
- 12 October 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (5) , 672-678
Open AccessDo rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? – Data from the FNIH and IMI-APPROACH cohorts
- Open Access
- 24 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325819
Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort
Objective: Knee osteoarthritis (OA) is a heterogeneous disease with different endotypes and phenotypes, resulting in patients’ varying clinical and structural progression. Several genomic markers have been associated with knee OA presence. This study aimed to find new associations of these genetic markers with knee OA progression and to investigate the risk of knee OA progression using a polygenic risk score (PRS). Methods: Data from knee OA patients (n = 297) from the IMI-APPROACH cohort with detailed measurements on disease progression were used. Knee OA progression definitions were based on the decrease in minimum joint space width in mm (minJSW; primary outcome), increase in pain on the Knee injury and Osteoarthritis Outcome Score (KOOS), and presence of radiographic OA (based on the Kellgren-Lawrence score) over 24 months. 30 previously reported single nucleotide polymorphisms (SNPs) associated with presence of OA irrespective of affected joints or knee OA specifically were investigated. We performed a SNP based genome-wide association analysis using the disease progression definitions. Furthermore, a PRS was created using the 30 presence SNPs to predict knee OA progression. Results: Existing genetic markers for knee OA presence were not found to be associated with knee OA progression. The PRS of the SNPs for knee OA presence did also not show significant predictive value for knee OA progression. Unexpectedly, nineteen different variants were associated significantly (P < 5 × 10−8) with minJSW decrease. Ten SNPs are located near protein coding genes PLCL2, CDYL2, and NTNG1, and several SNPs are located in or near long non-coding RNAs (lncRNA). Conclusions: The 30 OA risk SNPs individually and combined in a PRS are not associated with progression of knee OA in the IMI-APPROACH cohort. 19 different SNPs were associated with minJSW decrease. We demonstrated how to employ multiple bioinformatics tools to, despite a limited dataset, still prioritise potential biomarkers for associations to knee OA progression.
- 24 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325819
Open AccessGenetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort
Objective: Knee osteoarthritis (OA) is a heterogeneous disease with different endotypes and phenotypes, resulting in patients’ varying clinical and structural progression. Several genomic markers have been associated with knee OA presence. This study aimed to find new associations of these genetic markers with knee OA progression and to investigate the risk of knee OA progression using a polygenic risk score (PRS). Methods: Data from knee OA patients (n = 297) from the IMI-APPROACH cohort with detailed measurements on disease progression were used. Knee OA progression definitions were based on the decrease in minimum joint space width in mm (minJSW; primary outcome), increase in pain on the Knee injury and Osteoarthritis Outcome Score (KOOS), and presence of radiographic OA (based on the Kellgren-Lawrence score) over 24 months. 30 previously reported single nucleotide polymorphisms (SNPs) associated with presence of OA irrespective of affected joints or knee OA specifically were investigated. We performed a SNP based genome-wide association analysis using the disease progression definitions. Furthermore, a PRS was created using the 30 presence SNPs to predict knee OA progression. Results: Existing genetic markers for knee OA presence were not found to be associated with knee OA progression. The PRS of the SNPs for knee OA presence did also not show significant predictive value for knee OA progression. Unexpectedly, nineteen different variants were associated significantly (P < 5 × 10−8) with minJSW decrease. Ten SNPs are located near protein coding genes PLCL2, CDYL2, and NTNG1, and several SNPs are located in or near long non-coding RNAs (lncRNA). Conclusions: The 30 OA risk SNPs individually and combined in a PRS are not associated with progression of knee OA in the IMI-APPROACH cohort. 19 different SNPs were associated with minJSW decrease. We demonstrated how to employ multiple bioinformatics tools to, despite a limited dataset, still prioritise potential biomarkers for associations to knee OA progression.
- Open Access
- 9 June 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (12) , 1469
Deep Learning Based Automatic Ankle Tenosynovitis Quantification from MRI in Patients with Psoriatic Arthritis: A Feasibility Study
Background/Objectives: Tenosynovitis is a common feature of psoriatic arthritis (PsA) and is typically assessed using semi-quantitative magnetic resonance imaging (MRI) scoring. However, visual scoring s variability. This study evaluates a fully automated, deep-learning approach for ankle tenosynovitis segmentation and volume-based quantification from MRI in psoriatic arthritis (PsA) patients. Methods: We analyzed 364 ankle 3T MRI scans from 71 PsA patients. Four tenosynovitis pathologies were manually scored and used to create ground truth segmentations through a human–machine workflow. For each pathology, 30 annotated scans were used to train a deep-learning segmentation model based on the nnUNet framework, and 20 scans were used for testing, ensuring patient-level disjoint sets. Model performance was evaluated using Dice scores. Volumetric pathology measurements from test scans were compared to radiologist scores using Spearman correlation. Additionally, 218 serial MRI pairs were assessed to analyze the relationship between changes in pathology volume and changes in visual scores. Results: The segmentation model achieved promising performance on the test set, with mean Dice scores ranging from 0.84 to 0.92. Pathology volumes correlated with visual scores across all test MRIs (Spearman ρ = 0.52–0.62). Volume-based quantification captured changes in inflammation over time and identified subtle progression not reflected in semi-quantitative scores. Conclusions: Our automated segmentation tool enables fast and accurate quantification of ankle tenosynovitis in PsA patients. It may enhance sensitivity to disease progression and complement visual scoring through continuous, volume-based metrics.
- 9 June 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (12) , 1469
Open AccessDeep Learning Based Automatic Ankle Tenosynovitis Quantification from MRI in Patients with Psoriatic Arthritis: A Feasibility Study
Background/Objectives: Tenosynovitis is a common feature of psoriatic arthritis (PsA) and is typically assessed using semi-quantitative magnetic resonance imaging (MRI) scoring. However, visual scoring s variability. This study evaluates a fully automated, deep-learning approach for ankle tenosynovitis segmentation and volume-based quantification from MRI in psoriatic arthritis (PsA) patients. Methods: We analyzed 364 ankle 3T MRI scans from 71 PsA patients. Four tenosynovitis pathologies were manually scored and used to create ground truth segmentations through a human–machine workflow. For each pathology, 30 annotated scans were used to train a deep-learning segmentation model based on the nnUNet framework, and 20 scans were used for testing, ensuring patient-level disjoint sets. Model performance was evaluated using Dice scores. Volumetric pathology measurements from test scans were compared to radiologist scores using Spearman correlation. Additionally, 218 serial MRI pairs were assessed to analyze the relationship between changes in pathology volume and changes in visual scores. Results: The segmentation model achieved promising performance on the test set, with mean Dice scores ranging from 0.84 to 0.92. Pathology volumes correlated with visual scores across all test MRIs (Spearman ρ = 0.52–0.62). Volume-based quantification captured changes in inflammation over time and identified subtle progression not reflected in semi-quantitative scores. Conclusions: Our automated segmentation tool enables fast and accurate quantification of ankle tenosynovitis in PsA patients. It may enhance sensitivity to disease progression and complement visual scoring through continuous, volume-based metrics.
- Open Access
- 15 April 2025
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 66 (5) , 497-503
Application of knee joint distraction: challenges and opportunities
Knee osteoarthritis (OA) is a debilitating condition with limited treatment options beyond symptom management or total knee arthroplasty (TKA). For younger patients, TKA presents challenges, including higher failure rates and revision surgeries. Knee joint distraction (KJD) has emerged as a promising joint-preserving alternative for end-stage knee OA, demonstrating significant improvements in pain, function, and quality of life in clinical trials and clinical practice. Almost 20 years of research has highlighted KJD's capacity to delay or prevent TKA by promoting cartilage and subchondral bone repair through whole-joint remodeling. Recent studies, including a multicenter trial with a purpose-built distraction device, confirm the treatment's efficacy and durability, with benefits lasting up to 10 years. However, long-term outcomes remain limited, and variability in patient response underscores the need for refined predictive tools. Challenges include the high incidence of pin tract infections during treatment and integrating KJD into routine clinical practice, as highlighted by limited trial enrollment in the UK KARDS trial and variability in healthcare system compatibility. Future research should focus on minimizing complications, improving patient selection through advanced imaging and biomarker analyses, and further understanding the mechanisms underlying KJD-induced joint remodeling. Large-scale trials like the ongoing Dutch GODIVA study are poised to provide robust evidence for KJD's broader adoption, implementation, and reimbursement in healthcare systems. With continued advancements, KJD holds the potential to transform the management of knee OA, offering a viable alternative to TKA for younger patients and addressing a critical unmet need in OA care.
- 15 April 2025
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 66 (5) , 497-503
Open AccessApplication of knee joint distraction: challenges and opportunities
Knee osteoarthritis (OA) is a debilitating condition with limited treatment options beyond symptom management or total knee arthroplasty (TKA). For younger patients, TKA presents challenges, including higher failure rates and revision surgeries. Knee joint distraction (KJD) has emerged as a promising joint-preserving alternative for end-stage knee OA, demonstrating significant improvements in pain, function, and quality of life in clinical trials and clinical practice. Almost 20 years of research has highlighted KJD's capacity to delay or prevent TKA by promoting cartilage and subchondral bone repair through whole-joint remodeling. Recent studies, including a multicenter trial with a purpose-built distraction device, confirm the treatment's efficacy and durability, with benefits lasting up to 10 years. However, long-term outcomes remain limited, and variability in patient response underscores the need for refined predictive tools. Challenges include the high incidence of pin tract infections during treatment and integrating KJD into routine clinical practice, as highlighted by limited trial enrollment in the UK KARDS trial and variability in healthcare system compatibility. Future research should focus on minimizing complications, improving patient selection through advanced imaging and biomarker analyses, and further understanding the mechanisms underlying KJD-induced joint remodeling. Large-scale trials like the ongoing Dutch GODIVA study are poised to provide robust evidence for KJD's broader adoption, implementation, and reimbursement in healthcare systems. With continued advancements, KJD holds the potential to transform the management of knee OA, offering a viable alternative to TKA for younger patients and addressing a critical unmet need in OA care.